Sign in
4

Changes in Ownership

Taysha Gene Therapies, Inc. Filed Acc 0001209191-22-062615

Options or other derivatives

  • Director acquired 199,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Derivatives
Session R.A. II Director 2022-11-10 Grant or award · Employee Stock Option (right to buy) +199,500 199,500 D
Loading xslF345X03/doc4.xml…